Resultats globals: 3 registres trobats en 0.02 segons.
Articles, 3 registres trobats
Articles 3 registres trobats  
1.
8 p, 594.7 KB The Diabetes Unmet Need with Basal Insulin Evaluation (DUNE) study in type 2 diabetes : Achieving HbA1c targets with basal insulin in a real-world setting / Meneghini, Luigi F. (Parkland Health & Hospital System) ; Mauricio Puente, Dídac (Institut d'Investigació Biomèdica Sant Pau) ; Orsi, Emanuela (Fondazione Ca' Granda IRCCS) ; Lalic, Nebojsa M. (University of Belgrade) ; Cali, Anna M.G. (Sanofi) ; Westerbacka, Jukka (Sanofi) ; Stella, Peter (Sanofi) ; Candelas, Christophe (Sanofi) ; Pilorget, Valerie (Sanofi) ; Perfetti, Riccardo (Sanofi) ; Khunti, Kamlesh (University of Leicester) ; Universitat Autònoma de Barcelona
To describe in a real-world setting the achievement of physician-selected individualized HbA1c targets in individuals with type 2 diabetes, newly or recently initiated with basal insulin, and the association of hypoglycaemia with target achievement. [...]
2019 - 10.1111/dom.13673
Diabetes, Obesity and Metabolism, Vol. 21 Núm. 6 (june 2019) , p. 1429-1436  
2.
13 p, 1.6 MB Real-world outcomes of treatment with insulin glargine 300 U/mL versus standard-of-care in people with uncontrolled type 2 diabetes mellitus / Freemantle, Nick (University College London) ; Mauricio Puente, Dídac (Institut d'Investigació Biomèdica Sant Pau) ; Giaccari, Andrea (Università Cattolica del Sacro Cuore) ; Bailey, Timothy (AMCR Institute) ; Roussel, Ronan (UFR de Médecine. Paris University) ; Franco, Denise (CPCLIN Clinical Research Center) ; Berthou, Baptiste (IT&M Stats) ; Pilorget, Valerie (Sanofi) ; Westerbacka, Jukka (Sanofi) ; Bosnyak, Zsolt (Sanofi) ; Bonnemaire, Mireille (Sanofi) ; Cali, Anna M.G (Sanofi) ; Nguyên-Pascal, My-Liên (Sanofi) ; Penfornis, Alfred (Corbeil-Essonnes and Université Paris Sud) ; Perez-Maraver, Manuel (Hospital Universitari de Bellvitge) ; Seufert, Jochen (University of Freiburg) ; Sullivan, Sean D. (University of Washington) ; Wilding, John (University of Liverpool) ; Wysham, Carol (Multicare Rockwood Clinic) ; Davies, Melanie (University of Leicester) ; Universitat Autònoma de Barcelona
To compare real-world outcomes with newer (insulin glargine 300 U/mL; Gla-300) versus standard of care (SoC) basal insulins (BIs) in the REACH (insulin-naïve; NCT02967224) and REGAIN (basal insulin-treated; NCT02967211) studies in participants with uncontrolled type 2 diabetes (T2DM) in Europe and Brazil. [...]
2020 - 10.1080/03007995.2019.1708287
Current Medical Research and Opinion, Vol. 36 Núm. 4 (february 2020) , p. 571-581  
3.
6 p, 716.7 KB How many people with type 2 diabetes fulfil the eligibility criteria for randomized, controlled trials of insulin glargine 300 U/mL in a real-world setting? / Mauricio Puente, Dídac (Institut d'Investigació Biomèdica Sant Pau) ; Westerbacka, J. (Sanofi) ; Nicholls, C. (Sanofi) ; Wu, Jasmanda (Sanofi) ; Gupta, R. (Accenture) ; Eliasson, B. (Department of Medicine. University of Gothenburg. Sahlgrenska University Hospital)
Randomized controlled trial (RCT) populations often do not reflect those typically seen in clinical practice. This retrospective, observational cohort study analysed the real-world data of people with type 2 diabetes (T2DM) prescribed basal insulin analogues from electronic medical records (EMRs) in the Explorys database, which includes data from 39 integrated healthcare systems in the United States, to determine how representative selected RCTs investigating insulin glargine 300 U/mL (Gla-300) are of T2DM populations in a real-world setting. [...]
2021 - 10.1111/dom.14264
Diabetes, Obesity and Metabolism, Vol. 23 Núm. 3 (march 2021) , p. 838-843  

Vegeu també: autors amb noms similars
2 Westerbacka, Jukka
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.